Literature DB >> 15181071

Serum inhibin B and follicle-stimulating hormone levels as tools in the evaluation of infertile men: significance of adequate reference values from proven fertile men.

Anna-Maria Andersson1, Jørgen H Petersen, Niels Jørgensen, Tina K Jensen, Niels E Skakkebaek.   

Abstract

Inhibin B and FSH levels in 289 idiopathic infertile men were compared with reference materials consisting of 303 proven fertile men (reference group 1) and 307 healthy men from the general population with unknown fertility status (reference group 2). The diagnostic power of these two serum markers of spermatogenesis was evaluated by the use of receiver operating characteristic plot analysis, and an example of how both markers can be used simultaneously in a bivariate reference chart is presented. Inhibin B levels were significantly lower and FSH levels were significantly higher in the infertile men, compared with either reference group, but with significant overlap, especially with reference group 2. Nevertheless, approximately 50% of the infertile men had an inhibin B or FSH, respectively, below the 2.5 percentile or above the 97.5 percentile of reference group 1, whereas only approximately 25% of the infertile men had an inhibin B or FSH, respectively, below the 2.5 percentile or above the 97.5 percentile of reference group 2. Fourteen and 11% of reference group 2 had an inhibin B or FSH, respectively, below the 2.5 percentile or above the 97.5 percentile of reference group 1, suggesting that a significant number of individuals from the general population with unknown fertility but otherwise healthy may actually be subfertile. In conclusion, 1) proven fertile men constitute the most appropriate reference group in the evaluation of the FSH-inhibin B axis; the sensitivity of these markers to identify infertility increased by approximately 20% when fertile men rather than men from the general population were used as control group; 2) FSH alone had a slightly higher positive predictive value than inhibin B alone, but the positive predictive value were highest when both markers of spermatogenesis were used in an inhibin B/FSH ratio; and 3) a bivariate reference chart is a valuable objective tool in the simultaneous evaluation of FSH and inhibin B as two interrelated markers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181071     DOI: 10.1210/jc.2003-032148

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  32 in total

1.  Klinefelter syndrome with low gonadotropin levels.

Authors:  Kripa Elizabeth Cherian; Felix K Jebasingh; Nitin Kapoor; Thomas Vizhalil Paul
Journal:  BMJ Case Rep       Date:  2015-12-29

2.  Serum insulin-like factor 3 quantification by LC-MS/MS in male patients with hypogonadotropic hypogonadism and Klinefelter syndrome.

Authors:  Trine Holm Johannsen; Marie Lindhardt Ljubicic; Jacques Young; Séverine Trabado; Jørgen Holm Petersen; Allan Linneberg; Jakob Albrethsen; Anders Juul
Journal:  Endocrine       Date:  2021-01-22       Impact factor: 3.633

3.  The relation of germ cells per tubule in testes, serum inhibin B and FSH in cryptorchid boys.

Authors:  D Cortes; J Thorup; E Hogdall; B Norgaard-Pedersen; B L Petersen; C Hogdall
Journal:  Pediatr Surg Int       Date:  2006-12-14       Impact factor: 1.827

Review 4.  The role of vitamin D in male fertility: A focus on the testis.

Authors:  Cristina de Angelis; Mariano Galdiero; Claudia Pivonello; Francesco Garifalos; Davide Menafra; Federica Cariati; Ciro Salzano; Giacomo Galdiero; Mariangela Piscopo; Alfonso Vece; Annamaria Colao; Rosario Pivonello
Journal:  Rev Endocr Metab Disord       Date:  2017-09       Impact factor: 6.514

Review 5.  Vitamin D and male reproduction.

Authors:  Martin Blomberg Jensen
Journal:  Nat Rev Endocrinol       Date:  2014-01-14       Impact factor: 43.330

6.  Serum inhibin-b in fertile men is strongly correlated with low but not high sperm counts: a coordinated study of 1,797 European and US men.

Authors:  Niels Jørgensen; Fan Liu; Anna-Maria Andersson; Matti Vierula; D Stewart Irvine; Jacques Auger; Charlene K Brazil; Erma Z Drobnis; Tina K Jensen; Pierre Jouannet; James W Overstreet; J Bruce Redmon; Amy Sparks; Jorma Toppari; Christina Wang; Niels E Skakkebæk; Shanna H Swan
Journal:  Fertil Steril       Date:  2010-02-10       Impact factor: 7.329

7.  Testicular function among testicular cancer survivors treated with cisplatin-based chemotherapy.

Authors:  Takeshi Namekawa; Takashi Imamoto; Mayuko Kato; Tomokazu Sazuka; Miki Fuse; Shinichi Sakamoto; Koji Kawamura; Tomohiko Ichikawa
Journal:  Reprod Med Biol       Date:  2015-12-31

8.  Lack of specificity of plasma concentrations of inhibin B and follicle-stimulating hormone for identification of azoospermic survivors of childhood cancer: a report from the St Jude lifetime cohort study.

Authors:  Daniel M Green; Liang Zhu; Nan Zhang; Charles A Sklar; Raymond W Ke; William H Kutteh; James L Klosky; Sheri L Spunt; Monika L Metzger; Fariba Navid; DeoKumar Srivastava; Leslie L Robison; Melissa M Hudson
Journal:  J Clin Oncol       Date:  2013-02-19       Impact factor: 44.544

9.  Investigation of associations between exposures to pesticides and testosterone levels in Thai farmers.

Authors:  Parinya Panuwet; Chandresh Ladva; Dana Boyd Barr; Tippawan Prapamontol; John D Meeker; Priya Esilda D'Souza; Héctor Maldonado; P Barry Ryan; Mark G Robson
Journal:  Arch Environ Occup Health       Date:  2017-10-06       Impact factor: 1.663

10.  Polybrominated diphenyl ether exposure and reproductive hormones in North American men.

Authors:  Colleen M Makey; Michael D McClean; Lewis E Braverman; Elizabeth N Pearce; Andreas Sjödin; Janice Weinberg; Thomas F Webster
Journal:  Reprod Toxicol       Date:  2016-04-14       Impact factor: 3.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.